Thalys Medical Technology Group Corporation (SHA:603716)
China · Delayed Price · Currency is CNY 21.15
+0.59 (2.87%)
May 19, 2026, 10:15 AM CST
SHA:603716 Market Cap
SHA:603716 has a market cap or net worth of 4.4 billion as of May 18, 2026. Its market cap has increased by 144.90% in one year.
Market Cap
4.40B
Enterprise Value
4.60B
Revenue
971.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.15
Market Cap Chart
Since October 31, 2016, SHA:603716's market cap has increased from 1.97B to 4.40B, an increase of 123.01%. That is a compound annual growth rate of 8.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 4.40B | 3.88% |
| Dec 31, 2025 | 4.24B | 213.84% |
| Dec 31, 2024 | 1.35B | -36.50% |
| Dec 29, 2023 | 2.13B | 0.51% |
| Dec 30, 2022 | 2.12B | -24.46% |
| Dec 31, 2021 | 2.80B | -14.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Runda Medical Technology | 7.99B |
| Amoy Diagnostics | 7.83B |
| Beijing Strong Biotechnologies,Inc. | 7.64B |
| Maccura Biotechnology Co.Ltd | 6.25B |
| Cowealth Medical China | 5.76B |
| Shanghai Labway Clinical Laboratory | 4.24B |
| Guangdong Hybribio Biotech | 3.96B |
| Medicalsystem Biotechnology | 3.85B |